Concurrent Session 1B: Opioid Prescribing: Clinical Realities
Tracks
.
| Monday, November 9, 2026 |
| 1:30 PM - 3:00 PM |
Speaker
Ms Lucy Tran
PhD Candidate, Research Officer
NDARC
Co-occurring mental disorders and retention in buprenorphine and methadone treatment for opioid use disorder: A retrospective data linkage cohort study
1:35 PM - 1:45 PMBiography
Lucy Tran (BSci, BPsySc(Hons), MClinPsy) has worked across multiple projects examining the risks and harms associated with different illicit drug use and dependence. Lucy is a Clinical Psychologist and PhD candidate, with her PhD exploring the association of mental disorders on treatment outcomes among people dependent on methamphetamine or opioids.
Dr Tony Barnett
Research Fellow
The University Of Queensland
Long-acting injectable buprenorphine for the treatment of opioid concerns in Australia: Clinicians’ perspectives on socio-technical factors shaping innovation
1:45 PM - 1:55 PMBiography
Tony is an ARC DECRA Fellow at School of Psychology, The University of Queensland. His current work applies critical social science theory to: (1) opioid pharmacotherapies; and, (2) experiences of psychedelic consumption and policy.
Mr. Nicholas Kent
Policy & Advocacy Manager
Harm Reduction Victoria
Facilitating a lived & living experience review of opioid dependence treatment in Victoria
1:55 PM - 2:05 PMBiography
Nick Kent is an advocate working in harm reduction and drug policy reform, with a background in education and policy studies. Nick works on reform projects at state, national and international leves, and works with diverse communities of people who use drugs in community peer education, research and advocacy.
Professor Paul Dietze
Co_director, Disease Elimination Program
Burnet Institute
The relationship between opioid agonist therapy and reduced injecting frequency amongst people who inject drugs: Evidence from a prospective cohort study
2:05 PM - 2:15 PMBiography
Professor Dietze is one of Australia's leading alcohol and other drug years' with over 30 years' experience in the field.
Mrs Kendal Chidwick
PhD candidate, Research Fellow
National Drug and Alcohol Research Centre (NDARC), UNSW Sydney
Features Of Service Provision That Improve Outcomes Of Treatment For Opioid Use Disorder: Systematic Review And Metaanalysis
2:15 PM - 2:25 PMBiography
Kendal Chidwick (B. Pharm) is an epidemiologist and PhD candidate at NDARC. She is currently working on projects to synthesise the evidence on innovative approaches to delivering medicines for the treatment of opioid use disorder and the impacts of stopping or switching these medicines.
Dr Maja Lindegaard Moensted
Research Fellow
University Of Sydney
Zones of abandonment: Understanding LAIB discontinuation among Aboriginal people after release from custody
2:25 PM - 2:35 PMBiography
A qualitative researcher and sociologist, my work focuses on supporting people experiencing disadvantage to thrive. My research spans youth disadvantage, substance use, mental health, loneliness, chronic illness, homelessness and Aboriginal communities. Collectively my research provides insights into the complexity of health and social inequities across different populations and care contexts.
Dr Natasha Hall
Research Fellow
Eastern Health
Geographic and socioeconomic inequities in access to opioid agonist treatment in Australia
2:35 PM - 2:40 PMBiography
Dr Hall is a pharmacist and Early Career Research Fellow in the Health Economics Group at Monash University and Turning Point, Eastern Health, who works in health economics and health services research in substance use, addiction and mental health.
Dr Ashleigh Stewart
Research Fellow
Burnet Institute
